Loading…
Loading…
See exactly how IPOS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for IPOS and 80,000+ other tickers.
The fund primarily dedicates a minimum of 80% of its overall assets to the financial instruments included in its benchmark index. This benchmark is constituted by common equities, depositary receipts, real estate investment trusts (REITs), and units representing partnership interests. A maximum of 20% of the portfolio's value may additionally be allocated to specified derivatives such as futures, options, and swap agreements, alongside cash or highly liquid equivalents, and even common shares outside the primary index, all intended to aid the fund in closely replicating the index's performance. Notably, this fund operates on a non-diversified basis.
Four IPOs priced this past week, led by three sizable biotechs. They were joined by 11 blank check listings. Two IPOs are currently scheduled for the week ahead, though some smaller names may join the calendar late. Street research is expected for one company, and lock-up periods will be expiring for six companies.
Three IPOs priced this past week, joined by two SPACs, and one major issuer joined the pipeline. One IPO and one direct listing are currently scheduled in the week ahead, although some smaller issuers may join the calendar throughout the week. Street research is expected for one company in the week ahead, and three lock-up periods will be expiring.
Five small IPOs debuted and four SPACs listed this week as the government shutdown continues to complicate listings. Two sizable IPOs are scheduled for the week ahead, both of which launched after the government shutdown began. Street research is expected for six companies in the week ahead, and two lock-up periods will be expiring.
Kristin DeClark, Barclays Global Head of Technology Investment Banking, joins 'Money Movers' to discuss the IPO window reopening and her outlook for the space.
IPO market momentum accelerates as U.S. listings surge, boosting ETFs like FPX, IPO, FPXI and IPOS across the board.